This site is intended only for healthcare professionals resident in the United Kingdom

Information relating to specific disease areas aligned to Pfizer’s portfolio and other resources designed for Pfizer medicines.

See all Therapy areas

Learn about the efficacy and safety of Somavert, its tumour impact and its effect on co-morbidity management through clinical and real world data

The acromegaly disease activity tool designed to help monitor your patients

Advice and support services to help you and your patients optimise your experience with Somavert about the efficacy and safety of Somavert through clinical and real world data

Learn about funding and reimbursement England, Scotland, Wales and Northern Ireland

Watch and listen to acromegaly experts talk about various topics in the disease area as well as recordings from our National Nurse Meeting and the Acromegaly co-morbidity series

Click here for Somavert® (pegvisomant) Prescribing Information. Adverse event reporting information can be found at the bottom of the page.

Somavert is used in the treatment of adult patients with acromegaly who have had an inadequate response to surgery and/or radiation therapy and in whom an appropriate medical treatment with somatostatin analogues did not normalise IGF-I concentrations or was not tolerated.

Acromegaly Co-morbidities Webinars

Practical managment of diabetes in acromegaly. The recordings on this page are taken from a live meeting.

Dr Niki Karavitaki, Senior Clinical Lecturer in Endocrinology, Honourary Consultant Endocrinologist, Queen Elizabeth Hospital Birmingham discusses the background and impact of diabetes for acromegaly patients

Professor Aled Rees, Consultant Endocrinologist, School of Medicine, Cardiff University provides insights on auditing acromegaly patients with diabetes to ensure optimal management

Explore more

Contact us

To find out more about ACRODAT, supporting your patients or to order starter kits 

Contact us

** This is an optional area where footnotes can live.

Acromegaly expert webinars

Hear from experts on acromegaly and its management, captured from a variety of national and international opinion

Discover more webinars

** This is an optional area where footnotes can live.

National Nurse Meeting Recordings

Watch recordings from the 2020 national nurse meeting with discussions on enhancing nurse competency, acromegaly co-morbidities and auditing pituitary disorders 

Watch the recordings here

** This is an optional area where footnotes can live.


PP-SOM-GBR-0957. June 2021

For UK Healthcare Professionals*

These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.

I confirm that I am a healthcare professional* resident in the United Kingdom.

If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.

*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.

PP-PFE-GBR-2688. December 2020

Yes

No